{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:49:22Z","timestamp":1758991762594,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1053\/jinf.2001.0924","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T07:24:48Z","timestamp":1027668288000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Does Race Protect an Oriental Population From Developing Lipodystrophy in HIV-infected Individuals on HAART?"],"prefix":"10.1016","volume":"44","author":[{"given":"K.H.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.G.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jinf.2001.0924_RF1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"and HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Pallela","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jinf.2001.0924_RF2","first-page":"383","article-title":"Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease","volume":"25","author":"Vigouroux","year":"1999","journal-title":"Diabetes Metab"},{"key":"10.1053\/jinf.2001.0924_RF3","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jinf.2001.0924_RF4","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia and lipodystrophy","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/jinf.2001.0924_RF5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0924_RF6","unstructured":"Kingsley, L, Smit, E, Riddler, S, et al., Prevalence of lipodystrophy and metabolic abnormalities in the multicenter AIDS cohort study (MACS), 8th Conference on Retroviruses and Opportunistic Infections, 2001"},{"key":"10.1053\/jinf.2001.0924_RF7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment; insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1053\/jinf.2001.0924_RF8","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0924_RF9","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"Indinavir-associated lipodystrophy","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0924_RF10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jinf.2001.0924_RF11","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00002030-199911120-00007","article-title":"Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidemia and steroid hormone alterations","volume":"13","author":"Christeff","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0924_RF12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0924_RF13","unstructured":"Bernasconi, E, Boubaker, K, Sudre, P, et al., Metabolic side effects of antiretroviral therapy in the swiss cohort study, XIII International AIDS Conference"},{"key":"10.1053\/jinf.2001.0924_RF14","unstructured":"Domingo, P, Francia, E, Torres, OH, et al., Differential effects of zidovudine and stavudine on fat distribution and its associated metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy, XIII International AIDS Conference, 2000"},{"key":"10.1053\/jinf.2001.0924_RF15","unstructured":"Lichtenstein, K, Ward, D, Delaney, K, et al., Clinical factors related to the severity of fat redistribution in the HIV Outpatient Study (HOPS), XIII International AIDS Conference, 2000"},{"key":"10.1053\/jinf.2001.0924_RF16","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jinf.2001.0924_RF17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","article-title":"Randomizedplacebo-controlled trial of ritonavir in advanced HIV-1 disease","volume":"351","author":"Cameron","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jinf.2001.0924_RF18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/jinf.2001.0924_RF19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0026-0495(91)90059-6","article-title":"Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men","volume":"40","author":"Hommes","year":"1991","journal-title":"Metabolism"},{"key":"10.1053\/jinf.2001.0924_RF20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/jinf.2001.0924_RF21","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis ofHIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia, and insulin resistance","volume":"352","author":"Carr","year":"1998","journal-title":"Lancet"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445301909247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445301909247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:24:26Z","timestamp":1758986666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445301909247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0163445301909247"],"URL":"https:\/\/doi.org\/10.1053\/jinf.2001.0924","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Race Protect an Oriental Population From Developing Lipodystrophy in HIV-infected Individuals on HAART?","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jinf.2001.0924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}